US EditionTampa General Hospital and USF Health Complete First TricValve® Procedure in Florida in FDA Early Feasibility Study
- In April 2025, specialists at Tampa General Hospital and USF Health performed Florida’s inaugural TricValve procedure as part of an FDA Early Feasibility Study.
- This procedure addresses severe tricuspid regurgitation, a life-threatening heart valve disease affecting over 1.6 million Americans, which lacks effective treatments for high-risk surgery patients.
- The TricValve System is delivered through a minimally invasive catheter procedure that places valves into the two major veins leading to the heart’s right atrium, helping to decrease backward blood flow and eliminating the need for open-heart surgery.
- Dr. Matar emphasized Tampa General's dedication to innovation, highlighting the hospital’s prominent standing in cardiac care and advanced research that drives the development of cutting-edge treatments.
- This achievement highlights Tampa General's leadership in minimally invasive valve treatments, having completed the most TricValve procedures in the United States, with a mission to broaden patient access to critical, life-saving therapies.
53 Articles
53 Articles
The Berkshire Eagle
Tampa General Hospital and USF Health Complete First TricValve® Procedure in Florida in FDA Early Feasibility Study
The novel treatment is in development to address critical cardiac patients with a life-threatening condition and represents a significant milestone for the academic medical system's minimally invasive valve program.
Tampa General Hospital and USF Health Complete First TricValve® Procedure in Florida in FDA Early Feasibility Study - PressReach
The novel treatment is in development to address critical cardiac patients with a life-threatening condition and represents a significant milestone for the academic medical system’s minimally invasive valve program. TAMPA, Fla., May 9, 2025 /PRNewswire/ — Interventional structural cardiologists at Tampa General Hospital (TGH) and USF Health have completed the first procedure in Florida under the FDA Early Feasibility Study pathway for the TricVa…
Coverage Details
Bias Distribution
- 54% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
